OR56B1
gene geneOn this page
Summary
OR56B1 (olfactory receptor family 56 subfamily B member 1, HGNC:15245) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 56B1 (Q8NGI3). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 387748 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- MANE Select transcript:
NM_001005180
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15245 |
| Approved symbol | OR56B1 |
| Name | olfactory receptor family 56 subfamily B member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000181023 |
| Ensembl biotype | protein_coding |
| Entrez | 387748 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000317121
RefSeq mRNA: 1 — MANE Select: NM_001005180
NM_001005180
CCDS: CCDS31395
Canonical transcript exons
ENST00000317121 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001256577 | 5736448 | 5738523 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 94.02.
Top tissues by expression
96 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.02 | gold quality |
| colonic epithelium | UBERON:0000397 | 48.21 | gold quality |
| lymph node | UBERON:0000029 | 43.92 | gold quality |
| vermiform appendix | UBERON:0001154 | 43.92 | silver quality |
| calcaneal tendon | UBERON:0003701 | 42.64 | gold quality |
| spleen | UBERON:0002106 | 41.22 | silver quality |
| descending thoracic aorta | UBERON:0002345 | 39.31 | silver quality |
| granulocyte | CL:0000094 | 38.90 | gold quality |
| bone marrow cell | CL:0002092 | 38.46 | gold quality |
| right uterine tube | UBERON:0001302 | 37.70 | silver quality |
| bone marrow | UBERON:0002371 | 37.62 | gold quality |
| sural nerve | UBERON:0015488 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.47 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| tibial nerve | UBERON:0001323 | 36.35 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 36.01 | gold quality |
| endocervix | UBERON:0000458 | 35.76 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| gall bladder | UBERON:0002110 | 35.30 | gold quality |
| muscle tissue | UBERON:0002385 | 35.20 | gold quality |
| cortex of kidney | UBERON:0001225 | 34.46 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 34.45 | silver quality |
| small intestine | UBERON:0002108 | 34.26 | silver quality |
| rectum | UBERON:0001052 | 33.68 | gold quality |
| myometrium | UBERON:0001296 | 32.91 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 32.42 | gold quality |
| lower esophagus | UBERON:0013473 | 32.34 | gold quality |
| mucosa of stomach | UBERON:0001199 | 32.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or56b1b | ENSMUSG00000060105 |
| mus_musculus | Or56b1 | ENSMUSG00000073923 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 56B1 — Q8NGI3 (reviewed: Q8NGI3)
Alternative names: Olfactory receptor OR11-65
All UniProt accessions (1): Q8NGI3
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005180* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGI3-F1 | 83.55 | 0.43 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 106–198
Glycosylation sites (1): 12
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 20 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, NFE2L2.V2, REACTOME_OLFACTORY_SIGNALING_PATHWAY, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP
GO Biological Process (6): cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
130 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR56B1 | FRMPD1 | Q5SYB0 | 480 |
| OR56B1 | HEPHL1 | Q6MZM0 | 447 |
| OR56B1 | ZNF664 | Q8N3J9 | 447 |
| OR56B1 | TRERF1 | Q96PN7 | 400 |
| OR56B1 | UBR3 | Q6ZT12 | 395 |
| OR56B1 | ZFAT | Q9P243 | 358 |
| OR56B1 | KIF21A | Q7Z4S6 | 354 |
| OR56B1 | KIF21B | O75037 | 350 |
| OR56B1 | SMG7 | Q92540 | 306 |
| OR56B1 | CTC1 | Q2NKJ3 | 305 |
| OR56B1 | MIER1 | Q8N108 | 277 |
| OR56B1 | CSMD3 | Q7Z407 | 255 |
| OR56B1 | NISCH | Q9Y2I1 | 254 |
| OR56B1 | TFDP1 | Q14186 | 247 |
| OR56B1 | PLXNA1 | Q9UIW2 | 246 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3B3IT45, A6NGY5, A6NMU1, B3DH96, O88628, P0C646, P0C7T3, Q5J3E5, Q5J3G9, Q5J3M9, Q5QD29, Q6IF63, Q6W049, Q8NGB9, Q8NGD3, Q8NGF0, Q8NGF1, Q8NGH6, Q8NGH7, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGJ4, Q8NGJ8, Q8NGJ9, Q8NGK5, Q8NGK6, Q8NGV6, Q8NH53, Q8NH55, Q8NH56, Q8NH60, Q8NH61, Q8NH63, Q8NH67, Q8NH76, Q8NHC6, Q8TCB6, Q8VBV9
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
287 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5737300:A:AG | acceptor_gain | 0.6600 |
| 11:5736827:C:G | donor_gain | 0.6200 |
| 11:5737166:G:GT | donor_gain | 0.6200 |
| 11:5736563:TCCAG:T | donor_loss | 0.5900 |
| 11:5736564:CCAG:C | donor_loss | 0.5900 |
| 11:5736565:CAG:C | donor_loss | 0.5900 |
| 11:5736566:AG:A | donor_loss | 0.5900 |
| 11:5736567:GG:G | donor_loss | 0.5900 |
| 11:5736568:G:GG | donor_loss | 0.5900 |
| 11:5737119:G:GT | donor_gain | 0.5900 |
| 11:5736569:T:G | donor_loss | 0.5800 |
| 11:5736719:T:G | donor_gain | 0.5800 |
| 11:5737301:C:G | acceptor_gain | 0.5600 |
| 11:5736572:C:CG | donor_gain | 0.5400 |
| 11:5736720:G:GG | donor_gain | 0.5400 |
| 11:5737017:A:AG | acceptor_gain | 0.5300 |
| 11:5737018:G:GG | acceptor_gain | 0.5300 |
| 11:5737094:TCAC:T | donor_gain | 0.5300 |
| 11:5737310:TAGTG:T | acceptor_gain | 0.5300 |
| 11:5737311:AGTGA:A | acceptor_gain | 0.5300 |
| 11:5736749:T:TA | donor_gain | 0.5200 |
| 11:5736750:A:AA | donor_gain | 0.5200 |
| 11:5737171:GATC:G | donor_gain | 0.5200 |
| 11:5737222:A:AG | acceptor_gain | 0.5200 |
| 11:5737223:G:GG | acceptor_gain | 0.5200 |
| 11:5736562:TTCCA:T | donor_loss | 0.5100 |
| 11:5736637:GCAC:G | donor_gain | 0.5100 |
| 11:5737308:TGTAG:T | acceptor_gain | 0.5100 |
| 11:5737140:G:GG | donor_gain | 0.5000 |
| 11:5737311:A:AG | acceptor_gain | 0.5000 |
AlphaMissense
2113 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5736577:T:C | F21L | 0.959 |
| 11:5736579:C:A | F21L | 0.959 |
| 11:5736579:C:G | F21L | 0.959 |
| 11:5736578:T:C | F21S | 0.903 |
| 11:5737177:A:C | S221R | 0.882 |
| 11:5737179:T:A | S221R | 0.882 |
| 11:5737179:T:G | S221R | 0.882 |
| 11:5736835:T:C | F107L | 0.868 |
| 11:5736837:T:A | F107L | 0.868 |
| 11:5736837:T:G | F107L | 0.868 |
| 11:5737168:A:C | S218R | 0.851 |
| 11:5737170:T:A | S218R | 0.851 |
| 11:5737170:T:G | S218R | 0.851 |
| 11:5736578:T:G | F21C | 0.850 |
| 11:5737086:C:A | N190K | 0.849 |
| 11:5737086:C:G | N190K | 0.849 |
| 11:5737040:G:C | R175P | 0.834 |
| 11:5736892:T:C | C126R | 0.832 |
| 11:5737094:T:A | V193D | 0.825 |
| 11:5736832:T:A | C106S | 0.822 |
| 11:5736833:G:C | C106S | 0.822 |
| 11:5736843:G:C | Q109H | 0.818 |
| 11:5736843:G:T | Q109H | 0.818 |
| 11:5737072:T:C | C186R | 0.818 |
| 11:5737294:T:C | F260L | 0.817 |
| 11:5737296:T:A | F260L | 0.817 |
| 11:5737296:T:G | F260L | 0.817 |
| 11:5736757:G:C | G81R | 0.814 |
| 11:5736834:C:G | C106W | 0.814 |
| 11:5737078:T:A | C188S | 0.810 |
dbSNP variants (sampled 300 via entrez): RS1000176316 (11:5738176 C>G), RS1000613958 (11:5734935 T>A,C), RS1000645328 (11:5735242 G>C), RS1000672625 (11:5737737 A>G), RS1001189680 (11:5737990 T>A,G), RS1001277516 (11:5737840 T>G), RS1001311741 (11:5738090 G>GTT), RS1005062001 (11:5737445 C>A,G), RS1005357014 (11:5734512 T>C), RS1005634102 (11:5738703 G>C), RS1005932198 (11:5738488 C>T), RS1006201629 (11:5738686 A>C,G), RS1007428281 (11:5738838 A>G), RS1007934862 (11:5734681 A>G), RS1008762657 (11:5736791 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| hydroxyhydroquinone | increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Tretinoin | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.